12th Medication Safety Conference 2019
| 12th Medication Safety Conference 2019 | |
|---|---|
| Date | 2019-01-11 |
| Place | Dusit Thani Abu Dhabi, UAE |
Contents
CONFERENCE SUMMARY
The 12th Medication Safety Conference continues its mission of improving patient safety in the region. This year’s event will highlight the roles of health system integration, clinical excellence, and innovation in healthcare. This highly anticipated installment will take place from October 31 to November 3, 2019, at the Dusit Thani hotel in Abu Dhabi, United Arab Emirates.
The Medication Safety Conference is now on its 3rd year of collaboration with the American Society of Health-System Pharmacists (ASHP), which ensures greater access to well-regarded experts and global contemporary practice topics. The conference is also supported by the Department of Health – Abu Dhabi, the International Medication Safety Network (IMSN), the Institute for Safe Medication Practices (ISMP) and ISMP Canada. Building on its track record of success, the event will host over 1,200 delegates from the GCC and surrounding regions, including pharmacists, physicians, nurses, students and other healthcare professionals devoted to patient safety and in particular medication safety best practices.
The Medication Safety Conference delivers its scientific program through numerous tracks, expanding beyond just the pharmacist’s role in medication management. The streams focus on novel breakthrough topics that allow medical, nursing, allied health, and quality staff, as well as healthcare administrators, to remain abreast on patient safety issues. Moreover, through its accreditation, this event allows for healthcare clinicians to obtain continuing education credits and serves as a valuable platform for networking opportunities.
For the first time in Abu Dhabi, the Medication Safety Conference series is proud to announce the launch of the Genomics education series that will take place this year alongside the 12th Medication Safety Conference. A masterclass to introduce the genetic sequencing technology, gene-based disease risk stratification and the application of pharmacogenomics in different patient groups such as cancer, diabetes, and psychiatry, will run over the course of 10 informative lectures and is expected to acquire continuing medical education (CME) of 7 credit hours.
This year’s edition of the Medication Safety Conference will bring together a group of worldwide leaders in the field of pharmacy and medication safety to Abu Dhabi. Respected experts participating once again in this series include our keynote speaker Dr. Paul Abramowitz, Chief Executive Officer of the American Society of Health-System Pharmacists (ASHP) and Dr. Jeannell Mansur, Practice Leader for Medication Safety for Joint Commission Resources, along with many other highly renowned lecturers from across the globe.
Top Photos
Top Videos
Speakers
| Name | Country | Specialty |
|---|---|---|
| Imad Treish | United Arab Emirates | Pharmacy and Medicine |
| Zeina Khouri-Stevens | United Arab Emirates | Nursing |
| Susan E. Mazer | USA | Healthcare Management |
| Martin Egerth | Germany | Healthcare Management |
| Jeannell M. Mansur | USA | Pharmacy and Medicine |
| Kasey K. Thompson | USA | Pharmacy and Medicine |
| Maryanne Gillie | USA | Pharmacy and Medicine |
| Abdulrazaq Al Jazairi | KSA | Clinical Pharmacy Consultant |
| Douglas Scheckelhof | USA | Healthcare Management |
Speaker Highlights
Dr Imad Treish
He is the Oncology Chief Operating Officer at Abraaj Growth Markets Health Fund (AGHF) since March 2018. Prior to that, Dr. Treish was the Chief Operating Officer of the King Hussein Cancer Center in Amman, Jordan. He oversaw the operations in this world-renowned, 250-bed comprehensive cancer centre between 2009 and 2018.
Dr. Treish was the founding chairman of the Department of Pharmacy in KHCC between 2002 and 2009. He has extensive experience in oncology clinical pharmacy practice and established the first modern hospital pharmacy department in Jordan. In addition, Dr. Treish has a particular interest in the fields of cytotoxic drug safety and environmental controls to reduce cross-contamination of cytotoxic drugs. Moreover, Dr Treish is interested in cancer biomarkers and more specifically genomic markers of drug efficacy, toxicity, and economics.
Zeina Khouri-Stevens
Since 2014, Khouri-Stevens has served as the Chief Nursing Officer (CNO) of Johns Hopkins Aramco Healthcare (JHAH), where she oversees the Nursing and Clinical Services departments. Her tenure at JHAH has been defined by the advancement of nursing as a profession, in 2015 Khouri-Stevens established the Doctorate of Nursing program in collaboration with the Johns Hopkins School of Nursing. This program is the first of its kind to be offered in Saudi Arabia and enhances nurses’ clinical skills, develops their leadership skills and solidifies their role as an essential component in delivering quality healthcare.
Khouri-Stevens received her Bachelor of Science in Nursing from the American University of Beirut in 1993. In 1995, she received a Master’s of Science in Nursing, with a focus on critical care and trauma, from the University of San Francisco in California. In 2006, she was awarded a Doctorate in Nursing from the University of Maryland, with a focus on critical care and education. Her main research focus as a doctoral candidate was the relationship between critical thinking and clinical decision-making amongst critical care nurses.
Agenda
| October 31, 2019 | |
|---|---|
| Genomics Master Class | 9:00 AM-4:30 PM |
| November 1, 2019 | |
| Welcome Snacks and Coffee | 9:00 AM-9:30 AM |
| Opening Ceremony | 9:30 AM-10:00 AM |
| Music as Environmental Design | 10:00 AM-10:45 AM |
| Healthcare Innovation to Enhance Patient Care and Delivery | 10:45 AM-11:15 AM |
| Creating Change Through Innovation: The Future of Pharmacy Practice in the Age of Artificial Intelli | 11:15 AM-11:45 AM |
| Q & A Session | 11:45 AM-12:00 PM |
| Lunch Break & Prayer | 12:00 PM-1:30 PM |
| Risk of Anticoagulation: Changes in the US-based Joint Commission National Patient Safety Goal | 1:30 PM-2:00 PM |
| ASHP's Practice Advancement Initiative 2030 | 1:30 PM-2:00 PM |
| Pharmacist-led Thrombosis and Bleeding Risk Stratification: Impact on Adherence and Clinical Outcome | 2:00 PM-2:30 PM |
| Oncology Pharmacy Practice Model Advancement | 2:00 PM-2:30 PM |
| Urgent Care for Stroke Patients: Triage, Treatment and Transfer - | 2:30 PM-3:00 PM |
| Big Data to Support Innovation in Medication Safety | 2:30 PM-3:00 PM |
| Q & A Session | 3:00 PM-3:15 PM |
| Q & A Session | 3:00 PM-3:15 PM |
| Coffee Break & Poster Session | 3:15 PM-3:45 PM |
| Trust, Assertivess and Leadership: the Foundation for Safe and Effective Teams | 3:45 PM-4:15 PM |
| Pharmacogenomics - an Approach to Personalized Medicine | 3:45 PM-4:15 PM |
| Achieving Transformational Outcomes from Frontline to Boardroom | 4:15 PM-4:45 PM |
| Pharmacogenetic Implications in Cancer Patients | 4:15 PM-4:45 PM |
| Q & A Session | 4:45 PM-5:00 PM |
| Q & A Session | 4:45 PM-5:00 PM |
| November 2, 2019 | |
| Welcome Snacks & Coffee | 8:30 AM-9:00 AM |
| Welcome Remarks | 9:00 AM-9:05 AM |
| Creating a Culture of Ownership for Safety | 9:05 AM-9:45 AM |
| Patient Experience and the Role of Leadership | 9:45 AM-10:15 AM |
| The Application of Reliability Science and Patient-Centric Care in Healthcare | 10:15 AM-10:45 AM |
| Q & A Session | 10:45 AM-11:00 AM |
| Coffee Break & Poster Session | 11:00 AM-11:30 PM |
| Education to Practice in a High Tech Environment | 11:30 AM-12:00 PM |
| Polypharmacy in Geriatrics | 11:30 AM-12:00 PM |
| Mobile Application and Patient Experience | 12:00 PM-12:30 PM |
| Improving Safety Screening and Monitoring of Patients on Biologics | 12:00 PM-12:30 PM |
| Q & A Session | 12:30 PM-12:45 PM |
| Q & A Session | 12:30 PM-12:45 PM |
| Lunch Break | 12:45 PM-1:45 PM |
| Simple Vitamin. Great Impact. | 1:45 PM-2:00 PM |
| De-prescribing Proton Pump Inhibitors | 2:00 PM-2:15 PM |
| Common Drugs. Uncommon Indications | 2:15 PM-2:30 PM |
| Antimicrobial Stewardship Program in Ambulatory Care | 2:45 PM-3:00 PM |
| Coffee Break and collection of scores from judges | 2:45 PM-3:00 PM |
| Standardize 4 Safety initiative | 3:00 PM-3:30 PM |
| Mental and Physical Effects in Decreasing Opioid Usage on Long-Term Patients | 3:00 PM-3:30 PM |
| What is New in the 2019 Revised USP Chapter <797> | 3:30 PM-4:00 PM |
| Pain and the Patient Environment | 3:30 PM-4:00 PM |
| Q & A Session | 4:00 PM-4:15 PM |
| Q & A Session | 4:00 PM-4:15 PM |
| Closing Awards Ceremony | 4:15 PM-4:30 PM |
| November 3, 2019 | |
| How Using Concepts from the Diffusion of Innovation can Support your Performance Improvement Program | 8:30 AM-10:30 AM |
| An Approach to Optimizing Clinical Pharmacy Services Through Standardization | 8:30 AM-10:30 AM |
| Coffee Break | 10:30 AM-11:00 AM |
| Human Factors and Psychology of Change | 11:00 AM-1:00 PM |
| How to Control Safe Opioid Usage in Healthcare Settings | 11:00 AM-1:00 PM |
| Lunch Break | 1:00 PM-2:00 PM |
| The Patient Experience as an Ecosystem | 2:00 PM-4:00 PM |
| Focus on Interpersonal Skills - Sounds Logical, But Do You Have Them? | 2:00 PM-4:00 PM |
Top Quotes
Fun things happened
Reference
Verification history
1,927 days ago
1,927 days ago- 1,930 days ago
- View all verifications
